Dr David Haslam, chair of the UK’s National Obesity Forum, provides a useful review of SGLT-2 inhibitors and their ability to lower glucose level, body weight and blood pressure in people with type 2 diabetes.
Making Best Practice, Every Day Practice
How effective are SGLT-2 inhibitors in treating diabetes?
Educational Partners
